SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015504
Filing Date
2021-11-10
Accepted
2021-11-10 16:19:46
Documents
71
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q htbx-20210930x10q.htm   iXBRL 10-Q 1609862
2 EX-31.1 htbx-20210930xex31d1.htm EX-31.1 25897
3 EX-31.2 htbx-20210930xex31d2.htm EX-31.2 25294
4 EX-32.1 htbx-20210930xex32d1.htm EX-32.1 8071
5 EX-32.2 htbx-20210930xex32d2.htm EX-32.2 8083
  Complete submission text file 0001558370-21-015504.txt   7055826

Data Files

Seq Description Document Type Size
6 EX-101.SCH htbx-20210930.xsd EX-101.SCH 49195
7 EX-101.CAL htbx-20210930_cal.xml EX-101.CAL 76774
8 EX-101.DEF htbx-20210930_def.xml EX-101.DEF 153351
9 EX-101.LAB htbx-20210930_lab.xml EX-101.LAB 521049
10 EX-101.PRE htbx-20210930_pre.xml EX-101.PRE 376329
11 EXTRACTED XBRL INSTANCE DOCUMENT htbx-20210930x10q_htm.xml XML 1131916
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35994 | Film No.: 211396949
SIC: 2834 Pharmaceutical Preparations